Výsledky vyhledávání

Exogenous melatonin enhances the TRH-induced prolactin release in normally cycling women: A sex-specific effect

Autor: T. Wierdis, Giangiacomo Osella, Massimo Terzolo, Piero Paccotti, Alessandro Piovesan, Mirella Torta, T. Buniva, Alberto Angeli

Publikováno v: Gynecological Endocrinology. 5:83-94

The aim of the present study was to analyze the effects of exogenous melatonin (MT) upon pituitary and adrenal responsiveness to releasing hormones in different phases of the menstrual cycle. We evaluated the response of FSH and LH to 100 micrograms

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe6f5fbc3b46fc3012e29e73398a8b43
https://doi.org/10.3109/09513599109028431

Zobrazit plný text záznamu

Melatonin and human cancer

Autor: Mirella Torta, Massimo Terzolo, Alberto Angeli, Luigi Dogliotti, T. Buniva, R. Faggiuolo, Marco Tampellini, A. Bottini, Alfredo Berruti

Publikováno v: The Journal of Steroid Biochemistry and Molecular Biology. 37:983-987

A number of studies performed in vitro and on experimental animals supported the view that pineal gland inhibits neoplastic growth. Data in humans are scanty and controversial. In the present study we measured serum melatonin (MT), prolactin (PRL) an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4939e3b455e44097e11003541ecc8e4
https://doi.org/10.1016/0960-0760(90)90454-s

Zobrazit plný text záznamu

Circadian Profile of Serum Melatonin in Cushing's Disease and Acromegaly

Autor: Massimo Terzolo, Giorgio Borretta, T. Buniva, Mirella Torta, Piero Paccotti, Giangiacomo Osella, Alberto Angeli, Alessandro Piovesan

Publikováno v: Chronobiology International. 7:259-261

We evaluated the 24-hour profiles of serum melatonin (MT) and cortisol in 12 patients with Cushing’s syndrome and those of serum MT and growth hormone (GH) in 11 patients with acromegaly. The respective age-matched control groups consisted of 22 an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d990d1af144ba0a1dde5e88bdf5d8fb0
https://doi.org/10.3109/07420529009056984

Zobrazit plný text záznamu

Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study

Autor: T. Buniva, G. Richiardi, Alfredo Berruti, G. Moro, Luigi Dogliotti, A. Bottini, G. Porcile, S. Danese, M. G. Baù, P. Zola, Antonio Farris

Publikováno v: Cancer chemotherapy and pharmacology. 41(4)

We assessed the activity and tolerability of a cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy in 28 advanced breast cancer patients. The schedule of treatment was as follows: 60 mg/m2 epirubicin followed by 40 mg

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7653cd9ebd326ce4261e78112eeea6ff
https://pubmed.ncbi.nlm.nih.gov/9488603

Zobrazit plný text záznamu

Randomized comparison of goserelin acetate versus mitomycin C plus goserelin acetate in previously untreated prostate cancer patients with bone metastases

Autor: Roberto Tarabuzzi, T. Buniva, Pallotti S, Frezzotti L, Oscar Bertetto, R. Zolfanelli, Dario Fontana, Rossetti, Luigi Dogliotti, Cesare Bumma, G. Fasolis, G. Pagani, Alfredo Berruti

Publikováno v: Scopus-Elsevier

In a prospective trial conducted by the Gruppo Onco Urologico Piemontese, newly diagnosed prostate cancer patients with bone metastases were randomized to receive goserelin (3.6 mg subcutaneously every 4 weeks) or goserelin plus mitomycin at 14 mg/m2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d10240f0e1b7435fba07b3eaa6b6a36
http://hdl.handle.net/2318/40580

Zobrazit plný text záznamu

Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease

Autor: F Deltetto, Alfredo Berruti, Mirella Torta, Luigi Dogliotti, Destefanis M, T. Buniva, R. Cannone, G Moro, A. Gerbino, R. Faggiuolo, Gabriella Gorzegno, Antonio Farris, Marco Tampellini

Publikováno v: British Journal of Cancer

In order to study the relationship between circulating levels of CA 15-3 and the disease extent in predicting survival, we prospectively followed 312 breast cancer (BC) patients, from October 1988 to March 1995, from the time of first relapse. CA 15-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc84fec09074b47487a5142f62936145
http://hdl.handle.net/2318/38634

Zobrazit plný text záznamu

Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial

Autor: P Alquati, Alfredo Berruti, Antonio Farris, G Moro, D. Perroni, M Sussio, Luigi Dogliotti, Alberto Bottini, P Gosso, T. Buniva, Paolo Zola, M. G. Baù, F Deltetto, Maria Giuseppa Sarobba, C Monzeglio

Publikováno v: Scopus-Elsevier

PURPOSE Some evidence in vitro and in vivo shows that lonidamine (LND) can positively modulate the activity of doxorubicin and epirubicin (EPI). On this basis, a multicenter prospective randomized trial was performed in patients with advanced breast

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cd9cdea2ac252a2b90b861675f62ba7
http://hdl.handle.net/11379/469180

Zobrazit plný text záznamu

Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease

Autor: Alfredo Berruti, Mirella Torta, Marco Tampellini, T. Buniva, Luigi Dogliotti, Gabriella Gorzegno

The role of circulating tumour markers in providing prognostic information has been scarcely studied. We evaluated the prognostic significance of two mucinous markers: CA 15-3 and CA 125 in 115 breast cancer patients at first recurrence of disease. A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20731751daea1deee0b1b0c02f6a7f2c
http://hdl.handle.net/2318/37974

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání